These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9067919)

  • 1. Early experience with extended use of insulin-like growth factor-1 in advanced chronic renal failure.
    Ike JO; Fervenza FC; Hoffman AR; Yeh I; Hintz RL; Liu F; Rabkin R
    Kidney Int; 1997 Mar; 51(3):840-9. PubMed ID: 9067919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I treatment to enhance renal function in advanced chronic renal failure.
    Fervenza FC; Friedlaender MM; Ike JO; Rabkin R
    Ren Fail; 1998 Mar; 20(2):349-56. PubMed ID: 9574462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of IGF-I on renal function in end-stage chronic renal failure.
    Miller SB; Moulton M; O'Shea M; Hammerman MR
    Kidney Int; 1994 Jul; 46(1):201-7. PubMed ID: 7933838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure: relationship to growth and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Ulinski T; Mohan S; Kiepe D; Blum WF; Wingen AM; Mehls O; Tönshoff B
    Pediatr Nephrol; 2000 Jul; 14(7):589-97. PubMed ID: 10912524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease.
    Kuan Y; Surman J; Frystyk J; El Nahas AM; Flyvbjerg A; Haylor JL
    Growth Horm IGF Res; 2009 Jun; 19(3):219-25. PubMed ID: 19046909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of insulin-like growth factor-1 in advanced chronic renal failure.
    Rabkin R; Fervenza FC; Maidment H; Ike J; Hintz R; Liu F; Bloedow DC; Hoffman AR; Gesundheit N
    Kidney Int; 1996 Apr; 49(4):1134-40. PubMed ID: 8691735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
    Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
    Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group.
    Powell DR; Liu F; Baker BK; Hintz RL; Lee PD; Durham SK; Brewer ED; Frane JW; Watkins SL; Hogg RJ
    Kidney Int; 1997 Jun; 51(6):1970-9. PubMed ID: 9186890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure.
    Maxwell H; Nair DR; Dalton RN; Rigden SP; Rees L
    Pediatr Nephrol; 1995 Aug; 9(4):458-63. PubMed ID: 7577409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derangements of the somatotropic hormone axis in chronic renal failure.
    Tönshoff B; Blum WF; Mehls O
    Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of IGF-I on renal function in patients with chronic renal failure.
    O'Shea MH; Miller SB; Hammerman MR
    Am J Physiol; 1993 May; 264(5 Pt 2):F917-22. PubMed ID: 8498545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood.
    Tönshoff B; Blum WF; Wingen AM; Mehls O
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2684-91. PubMed ID: 7545697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor I improves renal function in patients with end-stage chronic renal failure.
    Vijayan A; Franklin SC; Behrend T; Hammerman MR; Miller SB
    Am J Physiol; 1999 Apr; 276(4):R929-34. PubMed ID: 10198369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of IGF system component levels and mitogenic activity of uremic serum on normal human osteoblasts.
    Wagner MS; Stracke S; Jehle PM; Keller F; Zellner D; Baylink DJ; Mohan S
    Nephron; 2000 Feb; 84(2):158-66. PubMed ID: 10657717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure.
    Hirschberg R; Kopple J; Lipsett P; Benjamin E; Minei J; Albertson T; Munger M; Metzler M; Zaloga G; Murray M; Lowry S; Conger J; McKeown W; O'shea M; Baughman R; Wood K; Haupt M; Kaiser R; Simms H; Warnock D; Summer W; Hintz R; Myers B; Haenftling K; Capra W
    Kidney Int; 1999 Jun; 55(6):2423-32. PubMed ID: 10354291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.
    Invitti C; Fatti L; Camboni MG; Porcu L; Danesi L; Delitala G; Cavagnini F
    J Endocrinol Invest; 1996 Sep; 19(8):548-55. PubMed ID: 8905479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor binding protein (IGFBP) displacers: relevance to the treatment of renal disease.
    Roelfsema V; Lane MH; Clark RG
    Pediatr Nephrol; 2000 Jul; 14(7):584-8. PubMed ID: 10912523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.